Euglycemic DKA on SGLT2 Inhibitors: How to Recognize and Treat It in an Emergency

Home > Euglycemic DKA on SGLT2 Inhibitors: How to Recognize and Treat It in an Emergency
Euglycemic DKA on SGLT2 Inhibitors: How to Recognize and Treat It in an Emergency
philip onyeaka Jan 1 2026 15

Euglycemic DKA Risk Assessment Tool

Symptom Assessment

This tool helps determine if you need immediate medical attention based on symptoms and risk factors.

Results will appear here...

EMERGENCY ALERT: This is a medical emergency. Call 911 immediately.

Important: Even with normal blood sugar, ketone testing is critical when using SGLT2 inhibitors. The FDA requires immediate medical attention for any symptoms of ketoacidosis, regardless of blood sugar levels.

Most people think diabetic ketoacidosis (DKA) means high blood sugar-usually over 250 mg/dL. But if you're taking an SGLT2 inhibitor like Farxiga, Jardiance, or Invokana, that assumption can be deadly. You can have full-blown DKA with blood sugar levels as low as 100 mg/dL. This is called euglycemic DKA, and it’s slipping through the cracks in emergency rooms across the country.

What Is Euglycemic DKA?

Euglycemic diabetic ketoacidosis (EDKA) is a dangerous form of DKA that happens when your body makes too many ketones-acidic fuel molecules-while your blood sugar stays normal or only slightly elevated. It’s not rare. Studies show it makes up 2.6% to 3.2% of all DKA cases. And among people on SGLT2 inhibitors, the risk is seven times higher than in those not taking these drugs.

SGLT2 inhibitors work by making your kidneys flush out extra sugar through urine. That sounds good for lowering blood sugar, but here’s the catch: your body thinks it’s running low on fuel. In response, your pancreas releases more glucagon and less insulin. That imbalance forces your fat cells to break down into ketones, even if your glucose levels look fine. The result? Acidosis without the red flag of high blood sugar.

Why It’s So Hard to Spot

The biggest problem with EDKA is that it doesn’t look like classic DKA. Patients show up with nausea, vomiting, abdominal pain, and extreme fatigue-symptoms that could be mistaken for the flu, food poisoning, or even a stomach bug. Many patients and even some doctors assume, “My blood sugar is normal, so I’m fine.” That’s the trap.

A 2015 study in Diabetes Care followed 13 cases of EDKA linked to SGLT2 inhibitors. In every case, the patients were initially dismissed because their glucose levels were below 250 mg/dL. One patient died before the diagnosis was made. Another was hospitalized for three days because no one checked for ketones.

The FDA issued a boxed warning in 2015, but awareness hasn’t kept up. Emergency departments still rely on glucose levels to rule out DKA. That’s outdated. EDKA doesn’t wait for your sugar to spike before it starts damaging your organs.

Who’s at Risk?

You don’t have to have type 1 diabetes to get EDKA. While it’s more common in type 1 patients, about 20% of cases occur in people with type 2 diabetes who’ve never had DKA before. Risk factors include:

  • Illness (like the flu, pneumonia, or a UTI)
  • Fasting or drastically cutting carbs
  • Surgery or major stress
  • Alcohol use
  • Pregnancy
  • Stopping insulin (even temporarily)
Even worse, SGLT2 inhibitors are often prescribed off-label to type 1 diabetes patients-about 8% of them use them. These patients are already at higher risk for DKA, and adding an SGLT2 inhibitor increases that risk to 5-12%.

Euglycemic DKA as a dark monster battling a nurse with insulin and dextrose, floating medical symbols in stormy sky.

How It’s Diagnosed

If you’re on an SGLT2 inhibitor and feel sick, don’t wait for your glucose to climb. Test for ketones-right away.

The diagnosis requires three things:

  • Blood glucose below 250 mg/dL
  • Metabolic acidosis (pH below 7.3 or bicarbonate below 18 mEq/L)
  • Elevated ketones (blood beta-hydroxybutyrate over 3 mmol/L)
Serum ketone testing is faster and more accurate than urine strips. Many emergency rooms now have point-of-care machines that give results in under 15 minutes. If you’re in the ER with nausea and you’re on an SGLT2 inhibitor, demand a serum ketone test. Don’t let them dismiss you because your sugar is “normal.”

Emergency Treatment: What Works

Treatment follows the same principles as classic DKA-but with key differences.

Fluids first: Start with 0.9% saline at 15-20 mL/kg in the first hour. Dehydration is severe, even if you don’t look it. But don’t overdo it-fluid overload can cause brain swelling.

Insulin is still needed: Give 0.1 units/kg/hour of IV insulin. But here’s the twist: you need to add dextrose much sooner than in hyperglycemic DKA. Because your blood sugar is already low, insulin will drop it even further. Once glucose hits 150-200 mg/dL, switch to 5% dextrose in saline to keep it stable while ketones clear.

Watch your potassium: Your serum potassium might look normal, but your total body potassium is usually low. You’ll lose it fast once insulin starts working. Replace it early and often. About 65% of EDKA patients need potassium supplementation.

Don’t confuse it with lactic acidosis: Some patients also have elevated lactate. Check both ketones and lactate to avoid misdiagnosis.

Family in kitchen at night, patient with glowing ketone alert, urgent call to 911, warning messages floating in air.

Prevention: What You Can Do

The best way to avoid EDKA is to know when to pause your SGLT2 inhibitor.

  • Stop taking it if you’re sick, fasting, or having surgery.
  • Keep eating carbs-even if you’re not hungry. Your body needs fuel.
  • Check ketones with a blood meter during illness, even if your glucose is normal.
  • Don’t rely on urine strips. They’re slow and unreliable.
  • Talk to your doctor before stopping insulin, even for a day.
The FDA now requires all SGLT2 inhibitor packaging to say: “Stop taking this medication and seek immediate medical help if you have symptoms of ketoacidosis-even if your blood sugar is normal.” That’s not a suggestion. It’s a lifesaving instruction.

What’s Changing Now?

Awareness has improved since 2015. EDKA now makes up 41% of all SGLT2-related DKA cases-up from 28%-which means more providers are catching it. But mortality hasn’t dropped enough.

New research is looking for early warning signs. A 2023 study found that a high ratio of acetoacetate to beta-hydroxybutyrate in the blood can predict EDKA 24 hours before symptoms appear. That’s promising. Future tools may combine this with HbA1c patterns and C-peptide levels to identify high-risk patients before they get sick.

For now, the rule is simple: If you’re on an SGLT2 inhibitor and you feel unwell, test your ketones. No exceptions. No delays. No assumptions.

Final Warning

SGLT2 inhibitors are powerful drugs. They help with weight loss, heart protection, and kidney safety. But they come with a silent killer: euglycemic DKA. It doesn’t announce itself with high blood sugar. It sneaks in with nausea, fatigue, and confusion.

If you’re taking one of these medications, make sure you-and your family-know the signs. Keep ketone strips or a blood meter at home. Know when to call 911. And never, ever assume normal blood sugar means you’re safe.

Tags:
Image

philip onyeaka

I am a pharmaceutical expert with a passion for writing about medication and diseases. I currently work in the industry, helping to develop and refine new treatments. In my free time, I enjoy sharing insights on supplements and their impacts. My goal is to educate and inform, making complex topics more accessible.

15 Comments

  • Image placeholder

    Phoebe McKenzie

    January 3, 2026 AT 01:54

    This is why people shouldn't be allowed to take SGLT2 inhibitors without a PhD in endocrinology. I've seen so many patients nearly die because they thought 'normal glucose' meant 'safe'-it's not just negligence, it's criminal. Doctors are lazy and patients are clueless. The FDA warning is a joke if it's not enforced with mandatory training. Someone needs to sue the pharmaceutical companies for this. I'm not even mad, I'm just disappointed.

  • Image placeholder

    gerard najera

    January 5, 2026 AT 00:09

    Ketones don't care about glucose numbers.

  • Image placeholder

    Stephen Gikuma

    January 6, 2026 AT 08:38

    Big Pharma pushed these drugs because they knew people would get sick and then need more meds. They're not trying to help-they're trying to hook you. Look at the timeline: 2015 warning, and now 41% of cases are EDKA? That's not progress, that's a marketing success. They're using your body as a lab. The government lets them do this because they're too busy taking bribes. You think your insulin is safe? Think again.

  • Image placeholder

    Bobby Collins

    January 8, 2026 AT 03:12

    okay but like... what if you're just trying to lose weight and you're on this drug and you get sick and your sugar is normal and you think you're fine but you're actually dying?? like?? why is this even a thing?? đŸ˜”â€đŸ’«

  • Image placeholder

    Layla Anna

    January 9, 2026 AT 21:00

    My cousin was on Jardiance and got really sick last year and the ER just sent her home because her sugar was 120... she ended up in ICU for 5 days 😭 I told her to always carry ketone strips now and she does. Everyone needs to know this. It's not just a diabetes thing-it's a life thing. ❀

  • Image placeholder

    Heather Josey

    January 10, 2026 AT 10:08

    Thank you for this comprehensive and clinically accurate overview. The distinction between euglycemic DKA and classic DKA is critically underappreciated in primary care and emergency settings. I urge all clinicians to incorporate routine serum ketone screening for patients on SGLT2 inhibitors presenting with nonspecific symptoms. Early intervention saves lives.

  • Image placeholder

    Donna Peplinskie

    January 12, 2026 AT 03:56

    Wow, this is so important-I’ve been telling my patients for years to check ketones even if their glucose is ‘fine,’ but most of them don’t even know what ketones are! I just ordered 20 blood ketone meters for my clinic. Let’s make sure no one gets sent home thinking they’re okay because their sugar is ‘normal.’ We’ve got to protect each other, y’all.

  • Image placeholder

    Olukayode Oguntulu

    January 13, 2026 AT 05:19

    The ontological dissonance inherent in the pharmacological paradigm of SGLT2 inhibition reveals a deeper epistemological failure in contemporary metabolic medicine. The reductionist reliance on glycemic metrics as a proxy for metabolic safety is a hermeneutic fallacy-a semiotic misalignment between physiological reality and diagnostic orthodoxy. The ketoacidotic cascade, once unmasked, exposes the ideological hegemony of pharmaceutical corporatism over clinical episteme.

  • Image placeholder

    jaspreet sandhu

    January 13, 2026 AT 20:37

    I don't know why people are making such a big deal about this. I've been on Farxiga for three years and I'm fine. My sugar is always normal. I don't check ketones. If you're getting sick, maybe you're just not eating right or you're lazy. This whole thing is overblown. People these days are too scared of everything. I know someone who got DKA once and he didn't even have an SGLT2 inhibitor. So it's not the drug, it's the person. Stop blaming the medicine and start blaming yourself.

  • Image placeholder

    Dusty Weeks

    January 15, 2026 AT 20:07

    so like... i was on invokana and got super dizzy and threw up and my sugar was 110 so i just laid down... turns out i had edka?? i had no idea. now i carry ketone strips everywhere. if you’re on one of these drugs and you feel off
 just test. please. i almost died 😅

  • Image placeholder

    Sally Denham-Vaughan

    January 17, 2026 AT 10:23

    My mom’s on Jardiance and she’s 72. I showed her this post and now she checks ketones every time she feels ‘off.’ She says she used to think ‘normal sugar = no problem’ but now she knows better. It’s crazy how much we don’t know until it almost kills us. So glad this info is out there đŸ’Ș

  • Image placeholder

    Bill Medley

    January 17, 2026 AT 18:49

    While the clinical presentation of euglycemic DKA is well-documented, the systemic failure in diagnostic protocols remains a critical gap in emergency medicine infrastructure. Standardized protocols must be implemented universally, with mandatory ketone testing for all SGLT2 inhibitor users presenting with gastrointestinal or fatigue-related symptoms.

  • Image placeholder

    Ann Romine

    January 19, 2026 AT 12:11

    I’ve been a nurse for 18 years and I didn’t know about this until last year. One patient, 52, type 2, on Farxiga, came in with abdominal pain and vomiting. Glucose was 130. We thought it was gastro. She coded two hours later. We didn’t check ketones. I still think about her. Please, if you’re on one of these drugs, learn this. Share it. Don’t wait until it’s too late.

  • Image placeholder

    Austin Mac-Anabraba

    January 20, 2026 AT 04:44

    Let’s be clear: the pharmaceutical industry engineered this crisis. SGLT2 inhibitors were approved based on surrogate endpoints-weight loss, HbA1c reduction-while ignoring the fundamental metabolic disruption they induce. The fact that ketone production is uncoupled from hyperglycemia is not an accident; it’s a design flaw masked as innovation. The FDA’s warning is a performative gesture. Real reform requires revoking these approvals and holding executives accountable.

  • Image placeholder

    Alex Warden

    January 21, 2026 AT 21:20

    Why do Americans always blame the drug? We got better healthcare in Russia. Back home, if you got sick with sugar problems, they just gave you insulin and told you to eat rice. No ketone tests. No fancy machines. Just medicine. Now everyone here is paranoid about every little thing. You don’t need to test ketones. Just don’t take the drug if you’re not sure. Simple.

Write a comment

Your email address will not be published. Required fields are marked *